The Clareon PanOptix Trifocal IOL: Visual Outcomes and Patient Satisfaction

Completed

Conditions studied: Cataract

In brief

This will be a single arm, open-label, prospective study of patient-reported outcomes of patients with bilateral implantation of the Panoptix or Panoptix Toric implant.

Key facts

Study ID

NCT05346172

Run by

Research Insight LLC

People needed

60

Starts

2022-06-17

Expected to finish

2023-03-10

Last updated by the study team

2023-03-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients with cataract and otherwise healthy eyes, not exhibiting any significant ocular morbidity that would be expected to influence outcome measures.
• Patients implanted with Clareon PanOptix or Clareon Panoptix Toric lenses bilaterally within 6 months of the survey administration.

You may not qualify if…

• Patients with visually significant comorbidities (corneal, retina, optic nerve disease) that could affect their satisfaction with surgery
• Patients with surgical complications either during or after surgery (capsule tears, iris trauma, decentered IOL, cystoid macular edema, etc.)
• Patients with previous refractive surgery within the past 6 months prior to cataract surgery
• Patients with > grade 1 posterior capsule opacity at their last visit

Where it is running

• Harvard Eye Associates — Laguna Hills, California, United States
• Florida Vision Institute — Stuart, Florida, United States
• IllinEye Consulting — Evansville, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.